keyword
https://read.qxmd.com/read/38751048/application-of-convolutional-neural-network-for-differentiating-ovarian-thecoma-fibroma-and-solid-ovarian-cancer-based-on-mri
#41
JOURNAL ARTICLE
Yuemei Zheng, Hong Wang, Tingting Weng, Qiong Li, Li Guo
BACKGROUND: Ovarian thecoma-fibroma and solid ovarian cancer have similar clinical and imaging features, and it is difficult for radiologists to differentiate them. Since the treatment and prognosis of them are different, accurate characterization is crucial. PURPOSE: To non-invasively differentiate ovarian thecoma-fibroma and solid ovarian cancer by convolutional neural network based on magnetic resonance imaging (MRI), and to provide the interpretability of the model...
May 15, 2024: Acta Radiologica
https://read.qxmd.com/read/38751020/alkaliptosis-induction-counteracts-paclitaxel-resistant-ovarian-cancer-cells-via-atp6v0d1-mediated-abcb1-inhibition
#42
JOURNAL ARTICLE
Fangquan Chen, Junhao Lin, Rui Kang, Daolin Tang, Jiao Liu
Paclitaxel serves as the cornerstone chemotherapy for ovarian cancer, yet its prolonged administration frequently culminates in drug resistance, presenting a substantial challenge. Here we reported that inducing alkaliptosis, rather than apoptosis or ferroptosis, effectively overcomes paclitaxel resistance. Mechanistically, ATPase H+ transporting V0 subunit D1 (ATP6V0D1), a key regulator of alkaliptosis, plays a pivotal role by mediating the downregulation of ATP-binding cassette subfamily B member 1 (ABCB1), a multidrug resistance protein...
May 15, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/38751015/m6a-mediated-hsa_circ_0061179-inhibits-dna-damage-in-ovarian-cancer-cells-via-mir-143-3p-timeless
#43
JOURNAL ARTICLE
Yuhong Zhang, Yuhong Wu, Xiu Shi, Hongmei Ding, Ying Zhou, Hanqing Chen, Fangrong Shen, Youguo Chen, Jinhua Zhou, Dingjie Zhou, Juan Wang
Ovarian cancer (OC) is among the most common and deadly solid malignancies in women. Despite many advances in OC research, the incidence of OC continues to rise, and its pathogenesis remains largely unknown. Herein, we elucidated the function of hsa_circ_0061179 in OC. The levels of hsa_circ_0061179, miR-143-3p, TIMELESS, and DNA damage repair-related proteins in OC or normal ovarian tissues and cells were measured using real-time quantitative polymerase chain reaction and immunoblotting. The biological effects of hsa_circ_0061179 and miR-143-3p on proliferation, clone formation, DNA damage, and apoptosis of OC cells were detected by the cell counting kit-8 assay, 5-methylethyl-2'-deoxyuridine, flow cytometry, the comet assay, and immunofluorescence staining combined with the confocal microscopy...
May 15, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/38750677/pro-inflammatory-cytokines-and-cxc-chemokines-as-game-changer-in-age-associated-prostate-cancer-and-ovarian-cancer-insights-from-preclinical-and-clinical-studies-outcomes
#44
REVIEW
Amin Ullah, Yongxiu Chen, Rajeev K Singla, Dan Cao, Bairong Shen
Prostate cancer (PC) and Ovarian cancer (OC) are two of the most common types of cancer that affect the reproductive systems of older men and women. These cancers are associated with a poor quality of life among the aged population. Therefore, finding new and innovative ways to detect, treat, and prevent these cancers in older patients is essential. Finding biomarkers for these malignancies will increase the chance of early detection and effective treatment, subsequently improving the survival rate. Studies have shown that the prevalence and health of some illnesses are linked to an impaired immune system...
May 13, 2024: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/38750579/novel-frontiers-in-urogenital-cancers-from-molecular-bases-to-preclinical-models-to-tailor-personalized-treatments-in-ovarian-and-prostate-cancer-patients
#45
REVIEW
Giada De Lazzari, Alena Opattova, Sabrina Arena
Over the last few decades, the incidence of urogenital cancers has exhibited diverse trends influenced by screening programs and geographical variations. Among women, there has been a consistent or even increased occurrence of endometrial and ovarian cancers; conversely, prostate cancer remains one of the most diagnosed malignancies, with a rise in reported cases, partly due to enhanced and improved screening efforts.Simultaneously, the landscape of cancer therapeutics has undergone a remarkable evolution, encompassing the introduction of targeted therapies and significant advancements in traditional chemotherapy...
May 15, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38750559/enhanced-anti-tumor-efficacy-with-multi-transgene-armed-mesenchymal-stem-cells-for-treating-peritoneal-carcinomatosis
#46
JOURNAL ARTICLE
Yoon Khei Ho, Jun Yung Woo, Kin Man Loke, Lih-Wen Deng, Heng-Phon Too
BACKGROUND: Mesenchymal stem cells (MSCs) have garnered significant interest for their tumor-tropic property, making them potential therapeutic delivery vehicles for cancer treatment. We have previously shown the significant anti-tumour activity in mice preclinical models and companion animals with naturally occurring cancers using non-virally engineered MSCs with a therapeutic transgene encoding cytosine deaminase and uracil phosphoribosyl transferase (CDUPRT) and green fluorescent protein (GFP)...
May 15, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38750408/diagnostic-utility-of-magnetic-resonance-imaging-in-discriminating-immature-teratoma-insights-from-a-case-series
#47
Ahmet Akçay, Zeynep Dönmez, Abdusselim Adil Peker, Hüseyin Toprak, Mehmet Ali Gültekin
Immature teratomas (IT) are rare germ cell tumors with malignant behavior, distinct from the benign mature teratomas. Clinical differentiation poses challenges, demanding a comprehensive, multidisciplinary diagnostic approach. This case series delves into the detailed radiological imaging findings of ITs. Pelvic MRI was conducted on five cases with adnexal masses, all of which were histopathologically confirmed as ITs. Radiologically, larger tumor size and scattered fatty components were key diagnostic indicators...
May 15, 2024: Journal of Clinical Ultrasound: JCU
https://read.qxmd.com/read/38750376/the-promise-and-challenges-of-ai-integration-in-ovarian-cancer-screenings
#48
JOURNAL ARTICLE
Sierra Silverwood, Anna Jeter, Margo Harrison
PURPOSE: Ovarian cancer is oftendiagnosed late due to vague symptoms, leading to poor survival rate. Improved screening tests could mitigate this issue. This narrative review examines the potential and challenges of integrating artificial intelligence (A.I.) into ovarian cancer screenings, with a focus on improving early detection, diagnosis, and personalized risk assessment. METHOD: A comprehensive review of existing literature was conducted, analyzing studies and discussions within the scientific community...
May 15, 2024: Reproductive Sciences
https://read.qxmd.com/read/38750351/senaparib-as-first-line-maintenance-therapy-in-advanced-ovarian-cancer-a-randomized-phase-3-trial
#49
JOURNAL ARTICLE
Xiaohua Wu, Jihong Liu, Jing Wang, Li Wang, Zhongqiu Lin, Xiaobin Wang, Jianqing Zhu, Beihua Kong, Junwei Fei, Ying Tang, Bairong Xia, Zhiqing Liang, Ke Wang, Yi Huang, Hong Zheng, An Lin, Kui Jiang, Wei Wang, Xin Wang, Ge Lou, Hongming Pan, Shuzhong Yao, Guiling Li, Min Hao, Yunlang Cai, Xuejun Chen, Zhijun Yang, Youguo Chen, Hongwu Wen, Pengpeng Qu, Cong Xu, Chih-Yi Hsieh
Poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors as maintenance therapy after first-line chemotherapy have improved progression-free survival in women with advanced ovarian cancer; however, not all PARP inhibitors can provide benefit for a biomarker-unselected population. Senaparib is a PARP inhibitor that demonstrated antitumor activity in patients with solid tumors, including ovarian cancer, in phase 1 studies. The multicenter, double-blind, phase 3 trial FLAMES randomized (2:1) 404 females with advanced ovarian cancer (International Federation of Gynecology and Obstetrics stage III-IV) and response to first-line platinum-based chemotherapy to senaparib 100 mg (n = 271) or placebo (n = 133) orally once daily for up to 2 years...
May 15, 2024: Nature Medicine
https://read.qxmd.com/read/38750182/effectiveness-and-safety-of-pd-1-pd-l1-inhibitors-monotherapy-in-patients-with-endometrial-cancer
#50
JOURNAL ARTICLE
Xiaoyan Wan, Jiezheng Huang, Liu Huang, Yibin Wang, Yiyuan Fu, Xiaolong Jin, Zheng Huang, Jian Xiong
BACKGROUND: Studies evaluating the effectiveness of immune checkpoint inhibitors (ICI) for endometrial cancer (EC) are limited. This study aimed to assess the efficacy of PD-1/PD-L1 inhibitors as monotherapy for EC by conducting a meta-analysis. The predictive significance of MMR status, a biomarker for ICI response, also required further investigation. METHODS: A systematic literature search was conducted in English databases until September 2023. The analysis included objective response rate (ORR), disease control rate (DCR), adverse events (AEs), and odds ratios (OR), along with their corresponding 95% confidence intervals (CI)...
May 15, 2024: Discover. Oncology
https://read.qxmd.com/read/38750159/identification-of-necroptosis-related-gene-signatures-for-predicting-the-prognosis-of-ovarian-cancer
#51
JOURNAL ARTICLE
Yuling Qin, Yawen Sheng, Mengxue Ren, Zitong Hou, Lu Xiao, Ruixue Chen
Ovarian cancer (OC) is one of the most prevalent and fatal malignant tumors of the female reproductive system. Our research aimed to develop a prognostic model to assist inclinical treatment decision-making.Utilizing data from The Cancer Genome Atlas (TCGA) and copy number variation (CNV) data from the University of California Santa Cruz (UCSC) database, we conducted analyses of differentially expressed genes (DEGs), gene function, and tumor microenvironment (TME) scores in various clusters of OC samples.Next, we classified participants into low-risk and high-risk groups based on the median risk score, thereby dividing both the training group and the entire group accordingly...
May 15, 2024: Scientific Reports
https://read.qxmd.com/read/38749171/feasibility-and-operative-outcomes-of-surgery-in-the-liver-area-in-advanced-ovarian-cancer
#52
JOURNAL ARTICLE
Andrea Rosati, Agostino M De Rose, Valerio Gallotta, Diana Giannarelli, Valentina Ghirardi, Matteo Pavone, Antonella De Palma, Carmine Conte, Claudia Marchetti, Valeria Gallucci, Francesco Ardito, Felice Giuliante, Denis Querleu, Giovanni Scambia, Anna Fagotti
OBJECTIVE: The study aimed to characterize intra-and postoperative complications according to a standardized anatomo-surgical classification for ovarian cancer metastases in the liver area. METHODS: Data from all patients with advanced ovarian cancer undergoing primary or secondary surgery with perihepatic liver involvement (May-2016 to May-2022), were retrospectively retrieved and classified according to a standardized anatomo-surgical classification, and clustered into four Classes: Class I "Peritoneal", Class II "Hepatoceliac-lymph-nodes", Class III "Parenchymal" and Class IV Mixed (≥ 2 classes)...
May 14, 2024: Gynecologic Oncology
https://read.qxmd.com/read/38748950/intimate-care-products-and-incidence-of-hormone-related-cancers-a-quantitative-bias-analysis
#53
JOURNAL ARTICLE
Katie M O'Brien, Nicolas Wentzensen, Kemi Ogunsina, Clarice R Weinberg, Aimee A D'Aloisio, Jessie K Edwards, Dale P Sandler
PURPOSE: Intimate care products may contain substances associated with increased risk of hormone-related cancers. The relationship between genital talc use and ovarian cancer, in particular, has been well studied, but concerns about recall bias and exposure misclassification have precluded conclusions. We examined the association between intimate care products and female hormone-related cancers, accounting for potential biases, using data from a US-based cohort study. METHODS: The Sister Study enrolled 50,884 women who had a sister with breast cancer...
May 15, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38748943/epidemiologic-methods-to-advance-our-understanding-of-ovarian-cancer-risk
#54
EDITORIAL
Holly R Harris, Colette P Davis, Kathryn L Terry
No abstract text is available yet for this article.
May 15, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38748789/n-myc-impairs-innate-immune-signaling-in-high-grade-serous-ovarian-carcinoma
#55
JOURNAL ARTICLE
Alex Miranda, Swetansu Pattnaik, Phineas T Hamilton, Monica Alvaro Fuss, Shreena Kalaria, Céline M Laumont, Julian Smazynski, Monica Mesa, Allyson Banville, Xinpei Jiang, Russell Jenkins, Israel Cañadas, Brad H Nelson
High-grade serous ovarian cancer (HGSC) is a challenging disease, especially for patients with immunologically "cold" tumors devoid of tumor-infiltrating lymphocytes (TILs). We found that HGSC exhibits among the highest levels of MYCN expression and transcriptional signature across human cancers, which is strongly linked to diminished features of antitumor immunity. N-MYC repressed basal and induced IFN type I signaling in HGSC cell lines, leading to decreased chemokine expression and T cell chemoattraction...
May 17, 2024: Science Advances
https://read.qxmd.com/read/38748383/cascade-genetic-testing-an-underutilized-pathway-to-equitable-cancer-care
#56
REVIEW
Roni Nitecki Wilke, Erica M Bednar, Sara Pirzadeh-Miller, Sayoni Lahiri, Isabel C Scarinci, Charles A Leath Iii, Melissa K Frey, Karen H Lu, J Alejandro Rauh-Hain
The Precision Medicine Initiative was launched upon the potential of genomic information to tailor medical care. Cascade genetic testing represents a powerful application of precision medicine and involves the process of familial diffusion or the "cascade" of genomic risk information. When an individual (proband) is found to carry a cancer-associated germline pathogenic mutation, the information should be cascaded or shared with at-risk relatives. First degree relatives have a 50% likelihood of carrying the same cancer-associated mutation...
May 15, 2024: Familial Cancer
https://read.qxmd.com/read/38748352/survival-outcomes-in-stage-iv-gastric-cancer-patients-with-krukenberg-tumors-a-systematic-review-and-meta-analysis
#57
REVIEW
Junaid Anwar, Ahmed Abdelhakeem, Muhammad Shariq Khan, Hafiz Muhammad Arslan, Juwairiya Shuroog, Zouina Sarfraz, Ali Saeed, Anwaar Saeed
BACKGROUND: Stage IV gastric cancer patients with Krukenberg tumors typically exhibit poor survival outcomes, often less than 2 years. The management of this tumor subgroup remains non-standardized, and the impact of oophorectomy on survival remains uncertain. In this study, we systematically analyzed survival outcomes among gastric cancer patients with ovarian metastases who underwent standard chemotherapy, surgical resection of ovarian metastases, or combined chemotherapy and surgery...
May 15, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38746870/characterization-of-innate-lymphoid-cell-subsets-infiltrating-melanoma-and-epithelial-ovarian-tumors
#58
JOURNAL ARTICLE
Douglas C Chung, Maryam Ghaedi, Kathrin Warner, Azin Sayad, Samuel D Saibil, Marcus Q Bernardini, Blaise A Clarke, Patricia A Shaw, Marcus O Butler, Alexandra Easson, Sorana Morrissy, Ben X Wang, Linh Nguyen, Pamela S Ohashi, Nicolas Jacquelot
The innate lymphoid cell (ILC) family is composed of heterogeneous innate effector and helper immune cells that preferentially reside in tissues where they promote tissue homeostasis. In cancer, they have been implicated in driving both pro- and anti-tumor responses. This apparent dichotomy highlights the need to better understand differences in the ILC composition and phenotype within different tumor types that could drive seemingly opposite anti-tumor responses. Here, we characterized the frequency and phenotype of various ILC subsets in melanoma metastases and primary epithelial ovarian tumors...
2024: Oncoimmunology
https://read.qxmd.com/read/38746682/mamilnet-advancing-precision-oncology-with-multi-scale-attentional-multi-instance-learning-for-whole-slide-image-analysis
#59
JOURNAL ARTICLE
Qinqing Wang, Qiu Bi, Linhao Qu, Yuchen Deng, Xianhong Wang, Yijun Zheng, Chenrong Li, Qingyin Meng, Kun Miao
BACKGROUND: Whole Slide Image (WSI) analysis, driven by deep learning algorithms, has the potential to revolutionize tumor detection, classification, and treatment response prediction. However, challenges persist, such as limited model generalizability across various cancer types, the labor-intensive nature of patch-level annotation, and the necessity of integrating multi-magnification information to attain a comprehensive understanding of pathological patterns. METHODS: In response to these challenges, we introduce MAMILNet, an innovative multi-scale attentional multi-instance learning framework for WSI analysis...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38746677/the-causal-effects-of-genetically-determined-immune-cells-on-gynecologic-malignancies-a-mendelian-randomization-study
#60
JOURNAL ARTICLE
Yan Li, Jingting Liu, Qiandan Wang, Yawei Zhou, Chunhua Zhang, Jianying Pei
BACKGROUND: Evidence from observational studies suggested a connection between immune cells and gynecologic malignancies. To investigate potential causative associations between immunophenotype traits and gynecologic malignancies, we used a two-sample Mendelian randomization analysis. METHODS: The genetic instrumental variables of 731 immunophenotypes of peripheral blood were obtained by the GWAS database; the GWAS data of common gynecologic cancers were obtained from FinnGen study...
2024: Frontiers in Oncology
keyword
keyword
751
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.